pimagedine has been researched along with Hearing Loss, Sensorineural in 1 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelly, TC | 1 |
| Whitworth, CA | 1 |
| Husain, K | 1 |
| Rybak, LP | 1 |
1 other study available for pimagedine and Hearing Loss, Sensorineural
| Article | Year |
|---|---|
Aminoguanidine reduces cisplatin ototoxicity.
Topics: Animals; Antineoplastic Agents; Audiometry, Evoked Response; Auditory Threshold; Cisplatin; Enzyme I | 2003 |